Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin C for prevention of acute kidney injury in high-risk ICU patients with positive NephroCheck
ACTRN12619000909123Phase 2Recruiting
- Sponsor
- Professor Rinaldo Bellomo
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ascorbic acid in acute kidney failure (AKF) (2 arms), sponsored by Professor Rinaldo Bellomo. Primary endpoint: Peak plasma creatinine. Started Aug 2019; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12619000909123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000909123.